Their lead program, AEB1102, aims to lower elevated arginine within the blood as enzyme replacement therapy for Arginase 1 deficiency and remedy of arginine-dependent tumors. With an amino acids supplier for nutraceuticals acid volume share of 56.8% within the food and dietary supplements application in 2022, it is anticipated to continue to steer the market over the forecast interval. 2022. Effect of lowering dietary crude protein on growth efficiency of fattening pigs: a meta-analysis.
Benvenuto!
